Genetic alterations that drive HCC development, including TERT promoter, TP53, VEGF, WNT/β-catenin signaling, and the mTOR pathways, are linked to the expression of potential surveillance biomarkers, such as AFP [18,19,20,21,22]. The gene discussed is AFP; the disease is hepatocellular carcinoma.